8S9V image
Entry Detail
PDB ID:
8S9V
EMDB ID:
Title:
CRISPR-Cas type III-D effector complex bound to a self-target RNA in the pre-cleavage state
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2023-03-30
Release Date:
2024-04-24
Method Details:
Experimental Method:
Resolution:
3.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Cas7-Cas5-Cas11
Chain IDs:A
Chain Length:791
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polypeptide(L)
Description:TIGR03984 family CRISPR-associated protein
Chain IDs:B
Chain Length:193
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polypeptide(L)
Description:Cas10
Chain IDs:C
Chain Length:575
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polypeptide(L)
Description:Cas7-2x
Chain IDs:D
Chain Length:522
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polypeptide(L)
Description:TIGR03986 family CRISPR-associated RAMP protein
Chain IDs:E
Chain Length:795
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polyribonucleotide
Description:CRISPR RNA
Chain IDs:F
Chain Length:37
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Polymer Type:polyribonucleotide
Description:Self-target RNA
Chain IDs:G
Chain Length:60
Number of Molecules:1
Biological Source:Synechocystis sp. PCC 6803
Ligand Molecules
Primary Citation
RNA targeting and cleavage by the type III-Dv CRISPR effector complex.
Nat Commun 15 3324 3324 (2024)
PMID: 38637512 DOI: 10.1038/s41467-024-47506-y

Abstact

CRISPR-Cas are adaptive immune systems in bacteria and archaea that utilize CRISPR RNA-guided surveillance complexes to target complementary RNA or DNA for destruction1-5. Target RNA cleavage at regular intervals is characteristic of type III effector complexes6-8. Here, we determine the structures of the Synechocystis type III-Dv complex, an apparent evolutionary intermediate from multi-protein to single-protein type III effectors9,10, in pre- and post-cleavage states. The structures show how multi-subunit fusion proteins in the effector are tethered together in an unusual arrangement to assemble into an active and programmable RNA endonuclease and how the effector utilizes a distinct mechanism for target RNA seeding from other type III effectors. Using structural, biochemical, and quantum/classical molecular dynamics simulation, we study the structure and dynamics of the three catalytic sites, where a 2'-OH of the ribose on the target RNA acts as a nucleophile for in line self-cleavage of the upstream scissile phosphate. Strikingly, the arrangement at the catalytic residues of most type III complexes resembles the active site of ribozymes, including the hammerhead, pistol, and Varkud satellite ribozymes. Our work provides detailed molecular insight into the mechanisms of RNA targeting and cleavage by an important intermediate in the evolution of type III effector complexes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures